HD-OPM Archive
Topics › Hormones, women's & men's health

Bisphosphonates for bone loss: fracture reductions summarized

Gokhan Can · Oct 13, 2024 · ♥ 4 reactions · 1 comments · original Facebook post
Hormones, women's & men's healthAging & longevity
AI summary & key facts

Review of bisphosphonate evidence for osteoporosis. Alendronate cuts vertebral and non-vertebral fractures by about 50% in women with prior vertebral fractures; yearly IV zoledronic acid cuts vertebral fractures 70% and hip fractures 40%; a 2017 meta-analysis found overall fracture OR 0.62. Not a heart topic but relevant to aging.

Bisphosphonates for bone loss: Reviewing clinical outcomes

Osteoporosis and Fracture Prevention:

Muscle Mass and Strength:

Bisphosphonates and Mortality:

Bisphosphonates and Cardiovascular Disease:

Bisphosphonates and Cancer:

Other Key Points:

mylongevityjourney.blogspot.comBisphosphonatesOsteoporosis and Fracture Prevention: Bisphosphonates are the most widely used medications for osteoporosis. Alendronate, risedronate, iba...mylongevityjourney.blogspot.com

Research cited

#muscle#mortality#osteoporosis#bones#cardiovascular#cancer#breastcancer#cardiovasculardisease
← newer: NLA consensus: apoB testing helps when LDL-C and risk are diolder: Personal labs on tirzepatide/retatrutide and 5 mg rosuvastat →